Mark L. Sanz, M.D.

Interventional Cardiology

Mark L. Sanz, M.D.












Specialty Interests

PTCA/Stent
Peripheral Vascular and Renal Angioplasty/Angiography
Coronary and Peripheral Atherectomy
Investigational Carotid Stents
Abdominal Aortic Aneurysm Stent-Grafts



Post Graduate Training

    Fellowship in Cardiology
    U. of Michigan Hospitals
    Ann Arbor, MI
    July 1985 - June 1988

    Chief Medical Resident
    Presbyterian-St. Lukes Medical Center
    Denver, CO
    July 1984 - June 1985

    Residency
    Presbyterian-St. Lukes Medical Center
    Internal Medicine
    Denver, CO
    July 1983 - June 1984

    Internship and Residency
    U. of Colorado Medical Center
    Internal Medicine
    Denver, CO
    July 1980 - June 1982


Education
M.D.
Univ. of Chicago Pritzker School of Medicine
Chicago, IL
June 1980



Board Certification
         Diplomate, National Board on Medical Examiners - July 1981
         Diplomate, American Board of Internal Medicine - September 1984, 076702
         Diplomate, A.B.I.M., Subspecialty in Cardiology - September 1987



Research Activities

Principal Investigator
TAMI (Thrombolysis and Angioplasty in Myocardial Infarction) Trials
St. Patrick Hospital
Missoula, MT

Principal Investigator
ACT (Abrupt Closure Trial in PTCA)
St. Patrick Hospital
Missoula, MT

Principal Investigator
Epilog (ReoPro) Trials including EPIC, Epilog, Epistent
1992 - 1998

Principal Investigator
Impact Trial (Integrilin)
1997 - 1998

Principal Investigator
Symphony Trial of Sibrafiban (2nd in Western US for patient volume)
1998 - 1999

Principal Investigator
PRESTO Trial
Tranilast to Prevent Restenosis
1999 - 2000

Principal Investigator
TARGET Trial (Aggrastat vs. Reopro)
1999 - 2000

Principal Investigator
Carotid Artery Stent Trial for Western Montana
2000 -

Principal Investigator
Accumetrix Trial
Platelet Aggregation Studies with PCI
2000 -

Principal Investigator

REPLACE Trial, Bivalirudin vs. Heparin in PCI
2000 -




Saint Patrick's Hospital and Health Sciences Center

International Heart Institute Foundation